NCT00796380|UnknownPhase 4DMC
Loading search results
Sponsor study identifier
interventional
1
0 countries
N/A
Study Start
December 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of this study is to evaluate the efficacy of Xingnaojing for the treatment of convulsive diseases; to investigate whether convulsion episodes can be induced or aggravated by Xingnaojing and the role inflammation plays in the process.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 21, 2008
Actual (reported)November 24, 2008
Actual (reported)December 2008
Date type not reportedThis date has not been verified as actual or estimated.
November 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
July 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Antipyretic rate , Frequency of convulsive episodes ,
one year
Frequency of convulsive episodes
1 year
injection
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
First Submitted
November 21, 2008
First Posted
November 24, 2008
Study Start
December 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2009
Estimated (date passed)Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 24, 2008
Record last verified: 2008-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: